A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Inhaled Doses Of PF-05212372.

Clinical trial NCT01415102 · COMPLETED

Trial details

NCT number: NCT01415102
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Phase 1 Single Dose Safety Toleration Pharmacokinetics

Start date: 2010-09-01
Primary completion: 2010-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.